Valsartan
Valsartan is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Valsartan; Generic name: VALSARTAN; Drug class: Angiotensin 2 Receptor Blocker [EPC].
| Brand name | Valsartan |
|---|---|
| Generic name | VALSARTAN |
| Drug class | Angiotensin 2 Receptor Blocker [EPC] |
| Manufacturer | AvPAK |
| Used for | 1 INDICATIONS AND USAGE Valsartan tablets are an angiotensin II receptor blocker (ARB) indicated for: • Hypertension , to lower blood pressure in adults and children 1 year and older. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions ( 1.1 ) • Heart failure (NYHA class II to IV), to reduce hospitalization for heart failure in adults ( 1.2 ) • Post-myocardial infarction , for the reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction in adults ( 1.3 ) 1.1 Hypertension Valsartan tablets are indicated for the |
| Dosage | 2 DOSAGE AND ADMINISTRATION Indication Starting Dose Dose Range* Hypertension Adults ( 2.2 ) 80 to 160 mg once daily 80 to 320 mg once daily 1 to 16 years ( 2.3 ) 1 mg/kg once daily Up to 40 mg daily 1 to 4 mg/kg once daily Up to 160 mg daily Heart Failure ( 2.4 ) 40 mg twice daily 40 to 160 mg twice daily Post-Myocardial Infarction ( 2.5 ) 20 mg twice daily 20 to 160 mg twice daily *As tolerated by patient 2.1 Important Dosage and Preparation Information Valsartan tablets and oral suspension ar |
| Warnings | WARNING: FETAL TOXICITY WARNING: FETAL TOXICITY • When pregnancy is detected, discontinue valsartan tablets as soon as possible. (5.1) • Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. (5.1) WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. • When pregnancy is detected, discontinue valsartan tablets as soon as possible. ( 5.1 ) • Drugs that act directly on the renin-angiotensin system can cause injury |
| Active ingredient(s) | VALSARTAN |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0878f27e-5368-c93f-e063-6394a90a1086 |